SWTXUnknownMid-Cap

SpringWorks Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for SpringWorks Therapeutics, Inc. (SWTX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are SWTX insiders buying or selling?

SpringWorks Therapeutics, Inc. insiders reported 5 open-market buys ($14.4M) and 50 sells ($417.8M) across 55 Form 4 filings — a net selling position of $403.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 5, 2025)

Total Form 4 filings
55
SEC EDGAR
Insider filers
13
Insider buys (5)
$14.4M
Insider sells (50)
$417.8M

Insider sentiment

Net selling

Net insider flow of $403.4M in net selling.

Recent SWTX insider transactions

DateInsiderRoleTypeSharesPriceValue
Mar 5, 2025Badreddin EdrisChief Operating OfficerSale20.0K$54.23$1.1M
Mar 5, 2025Saqib IslamChief Executive OfficerSale49.0K$54.24$2.7M
Feb 24, 2025Saqib IslamChief Executive OfficerSale29.3K$60.30$1.8M
Feb 24, 2025Bhavesh AsharChief Commercial OfficerSale1.0K$61.19$62.2K
Feb 24, 2025Daniel LynchDirectorSale47.6K$60.22$2.9M
Feb 19, 2025Saqib IslamChief Executive OfficerSale10.7K$59.92$639.5K
Feb 19, 2025Daniel LynchDirectorSale400$60.00$24.0K
Feb 13, 2025Daniel PichlChief People OfficerSale29.8K$54.36$1.6M
Feb 13, 2025Daniel LynchDirectorSale175.0K$54.46$9.5M
Feb 13, 2025Saqib IslamChief Executive OfficerSale48.0K$53.30$2.6M
Feb 13, 2025Julie HambletonDirectorSale13.8K$53.01$730.2K
Feb 13, 2025Badreddin EdrisChief Operating OfficerSale30.0K$53.13$1.6M
Dec 5, 2024Badreddin EdrisChief Operating OfficerSale20.0K$41.97$839.3K
Dec 4, 2024Saqib IslamChief Executive OfficerSale49.0K$41.37$2.0M
Sep 4, 2024Saqib IslamChief Executive OfficerSale49.0K$40.57$2.0M
Sep 4, 2024Badreddin EdrisChief Operating OfficerSale20.0K$40.65$813.0K
Jun 5, 2024Saqib IslamChief Executive OfficerSale49.0K$39.90$2.0M
Jun 5, 2024Julie HambletonDirectorSale4.6K$40.03$186.0K
Jun 5, 2024Badreddin EdrisChief Operating OfficerSale20.0K$40.07$801.4K
Feb 20, 2024Daniel PichlChief People OfficerSale15.0K$50.10$751.5K
Feb 6, 2024Bhavesh AsharChief Commercial OfficerSale8.1K$47.34$381.4K
Feb 6, 2024Daniel PichlChief People OfficerSale26.2K$44.32$1.2M
Jul 21, 2023Julie HambletonDirectorSale2.4K$29.31$70.9K
Jun 22, 2023Julie HambletonDirectorSale2.4K$26.92$64.6K
Mar 20, 2023Jeffrey Lawrence SchwartzDirectorSale1.8M$28.50$49.9M

Showing the 25 most recent of 55 Form 4 filings for SpringWorks Therapeutics, Inc..

Most active SWTX insiders

  • Saqib Islam12 filings
  • ORBIMED ADVISORS LLC9 filings
  • Badreddin Edris7 filings
  • Julie Hambleton5 filings
  • Daniel Pichl4 filings

Ask anything about SWTX insider activity

Use Trabud's AI agent to query SpringWorks Therapeutics, Inc.'s Form 4 history in plain English — "Show me SWTX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

SWTX insider trading FAQ

Are SpringWorks Therapeutics, Inc. insiders buying or selling?

Across 55 SEC Form 4 filings, SpringWorks Therapeutics, Inc. (SWTX) insiders reported 5 open-market purchases totaling $14.4M and 50 sales totaling $417.8M. That is a net selling position of $403.4M.

How many insiders trade SWTX stock?

13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for SpringWorks Therapeutics, Inc.. The most recent filing was accepted on Mar 5, 2025.

Where does Trabud get SWTX insider trading data?

All SWTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content